Number of the records: 1
pramipexol
SYS d000077487 LBL 00000cz--a2200181n--4500 005 20250606222649.0 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 $d BA006 065 $a D03.383.129.708.089.514 065 $a D03.633.100.185.514 066 $a 01 $c 03 150 $a pramipexol $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzotiazol $2 slo 450 $w v $a 2-amino-6-propylaminotetrahydrobenzotiazol $2 slo 450 $w v $a 4,5,6,7-tetrahydro-N6-propyl-2,6-benzotiazol-diamín $2 slo 450 $w v $a 6,7-tetrahydro-N6-propyl-2,6-benzotiazoldiamín dihydrochlorid monohydrát $2 slo 450 $w v $a Mirapex $2 slo 450 $w v $a Pramipexol $2 slo 450 $w v $a pramipexol dihydrobromid, (+-)-izomér $2 slo 450 $w v $a pramipexol dihydrochlorid, (S)-izomér $2 slo 450 $w v $a pramipexol, (+-)-izomér $2 slo 450 $w v $a pramipexol dihydrochlorid $2 slo 450 $w v $a pramipexol dihydrochlorid bezvodý $2 slo 450 $w v $a pramipexol dihydrochlorid monohydrát $2 slo 450 $w v $a Sifrol $2 slo 450 $w v $a SND-919 $2 slo 550 $7 sllk_us_auth*d000975 $Y Antioxidants $w P $a antioxidanty 550 $7 sllk_us_auth*d000978 $Y Antiparkinson Agents $w P $a antiparkinsoniká 550 $7 sllk_us_auth*d018491 $Y Dopamine Agonists $w P $a agonisty dopamínu 665 $a 2019 (1989) $2 eng 680 9-
$i A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME. $2 eng 750 -2
$a Pramipexole $2 eng 980 $x M
Number of the records: 1